Accreditation/Credit Designation

Physicians' Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians' Education Resource®, LLC, designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians’ Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 1.5 Contact Hours.

Acknowledgment of Commercial Support

This activity is supported by educational grants from Celgene Corporation and Incyte Corporation.

Community Practice Connections™ Working Group to Optimize Outcomes in Myelofibrosis and Polycythemia Vera: Real-World Applications for Nurses

Release Date: June 30, 2019
Expiration Date: June 30, 2020
Media: Internet - based

Activity Overview

Community Practice Connections™: Working Group to Optimize Outcomes in Myelofibrosis and Polycythemia Vera: Real-World Applications for Nurses provides case-based discussion of clinical data guiding therapy for patients with myeloproliferative neoplasms (MPNs). Interactive clinical vignettes are followed by short video interviews with leading experts in the management of patients with hematologic malignancies. The video interviews address decision points in the clinical vignettes, as well as questions commonly faced in the community oncology practice setting by healthcare professionals engaged in the care of patients with MPNs.

Benefits of Participating

  • Gain insights into risk stratification in patients with myelofibrosis (MF)
  • Learn about the latest clinical data on JAK inhibitors in patients with MF
  • Expand knowledge of new agents to manage MF-associated anemia
  • Develop strategies to ensure patient access to and compliance with medical regimens

CME Activity Table of Contents

  • A Patient With Primary Myelofibrosis
    • Diagnosis and Risk Stratification
    • Treatment of Symptoms
    • Management of Ruxolitinib-Associated Anemia

Acknowledgement of Commercial Support

This activity is supported by educational grants from Celgene Corporation and Incyte Corporation.

Instructions for This Activity and Receiving Credit

  • You will need to log in to participate in the activity.
  • Each presentation may contain an interactive question(s). You may move forward through the presentation; however, you may not go back to change answers or review audio files/content until you finish the presentation.
  • At the end of the activity, educational content/audio files will be available for your reference.
  • In order to receive a CME/CE certificate, you must complete the activity.
  • Complete the Posttest and pass with a score of 70% or higher, complete the Evaluation, and then click on “Request for Credit.” You may immediately download a CME/CE certificate upon completion of these steps.

Target Audience

This educational program is directed toward nurses and other healthcare professionals with an interest in the treatment of hematologic malignancies.

Learning Objectives

Upon successful completion of this activity, you should be better prepared to:

  • Determine the differential presentations of myeloproliferative neoplasms (MPNs) and testing methods to stratify risk in patients with these hematologic malignancies.
  • Describe key evidence from recent clinical trials concerning the management of MPNs.
  • Place landmark findings from trials conducted in patients with MPNs into the context of discussions with patients about care they receive for these hematologic malignancies.
  • Apply best nursing practices to effectively counsel patients with MPNs concerning treatment-related toxicities and management of disease-related symptoms.

Faculty, Staff, and Planners’ Disclosures


Daniel J. DeAngelo
Daniel J. DeAngelo, MD, PhD
Professor of Medicine
Harvard Medical School
Chief, Division of Leukemia
Dana-Farber Cancer Institute
Boston, MA

Disclosures: Grant Research Support: AbbVie, Novartis, GlycoMimetics, Blueprint; Consultant: Amgen, Pfizer, Novartis, Blueprint, Shire, Incyte, Takeda.

Ilene Galinsky
Ilene Galinsky, MSN, ANP-C
Senior Program Research Nurse Practitioner for the Adult Leukemia Program
Dana-Farber Cancer Institute
Boston, MA

Disclosures: Ilene Galinsky has no relevant financial relationships with commercial interests to disclose.

Rami S. Komrokji
Rami S. Komrokji, MD
Senior Member and Professor of Oncologic Sciences
Section Head - Leukemia and Myelodysplastic Syndromes
Vice Chair - Malignant Hematology Department
Moffitt Cancer Center
Tampa, FL

Disclosures: Consultant: Celgene, Jazz, Pfizer, DSI, Incyte, Johnson & Johnson, Novartis; Speakers Bureau: Jazz, Novartis.

Mayra Lee
Mayra Lee, RN
Moffitt Cancer Center
Tampa, FL

Disclosures: Mayra Lee has no relevant financial relationships with commercial interests to disclose.

The staff of Physicians' Education Resource®, LLC (PER®), have no relevant financial relationships with commercial interests to disclose.

Disclosure Policy and Resolution of Conflicts of Interest (COI)

As a sponsor accredited by the ACCME, it is the policy of PER® to ensure fair balance, independence, objectivity, and scientific rigor in all of its CME/CE activities. In compliance with ACCME guidelines, PER® requires everyone who is in a position to control the content of a CME/CE activity to disclose all relevant financial relationships with commercial interests. The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months that creates a COI.

Additionally, PER® is required by ACCME to resolve all COI. PER® has identified and resolved all COI prior to the start of this activity by using a multistep process.

Off-Label Disclosure and Disclaimer

This CME/CE activity may or may not discuss investigational, unapproved, or off-label use of drugs. Participants are advised to consult prescribing information for any products discussed. The information provided in this CME/CE activity is for continuing medical and nursing education purposes only and is not meant to substitute for the independent clinical judgment of a physician or nurse relative to diagnostic or treatment options for a specific patient’s medical condition.

The opinions expressed in the content are solely those of the individual faculty members, and do not reflect those of PER® or any of the companies that provided commercial support for this program.

Login or Register to Start Activity

Please use the form below to Register or Log In to begin Activity.

*Required Fields
Calendar of Events
Filter By